WallStreetZenWallStreetZen

NASDAQ: JANX
Janux Therapeutics Inc Earnings & Revenue

JANX past revenue growth

How has JANX's revenue growth performed historically?
Company
-6.14%
Industry
169.3%
Market
17.86%
JANX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
JANX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance

JANX earnings and revenue history

Current Revenue
$8.1M
Current Earnings
-$58.3M
Current Profit Margin
-721.2%

JANX Return on Equity

Current Company
-17.9%
Current Industry
-63.4%
Current Market
188%
JANX's Return on Equity (-17.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when JANX announces earnings.

JANX Return on Assets

Current Company
-16%
Current Industry
3.2%
JANX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

JANX Return on Capital Employed

Current Company
-15.87%
Current Industry
19.9%
JANX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

JANX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
JANX$8.08M-$56.34M-$58.29M+49.08%N/A
SNDX$0.00-$208.40M-$209.36M-100.00%N/A
RNA$9.56M-$207.14M-$212.22M+90.71%N/A
GPCR$0.00-$88.46M-$89.62MN/AN/A
CPRX$398.20M$127.65M$71.41M+280.39%+21.25%

JANX earnings dates

Next earnings date
May 10, 2024

Janux Therapeutics Earnings & Revenue FAQ

What were JANX's earnings last quarter?

On Invalid Date, Janux Therapeutics (NASDAQ: JANX) reported Q4 2023 earnings per share (EPS) of -$0.24, up 38.46% year over year. Total Janux Therapeutics earnings for the quarter were -$11.76 million. In the same quarter last year, Janux Therapeutics's earnings per share (EPS) was -$0.39.

If you're new to stock investing, here's how to buy Janux Therapeutics stock.

What was JANX's earnings growth in the past year?

As of Q1 2024, Janux Therapeutics's earnings has grown year over year. Janux Therapeutics's earnings in the past year totalled -$58.29 million.

What is JANX's earnings date?

Janux Therapeutics's earnings date is Invalid Date. Add JANX to your watchlist to be reminded of JANX's next earnings announcement.

What was JANX's revenue last quarter?

On Invalid Date, Janux Therapeutics (NASDAQ: JANX) reported Q4 2023 revenue of $2.46 million up 13.5% year over year. In the same quarter last year, Janux Therapeutics's revenue was $2.85 million.

What was JANX's revenue growth in the past year?

As of Q1 2024, Janux Therapeutics's revenue has grown -6.14% year over year. This is 175.44 percentage points lower than the US Biotechnology industry revenue growth rate of 169.3%. Janux Therapeutics's revenue in the past year totalled $8.08 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.